How to Evaluate Acne in Reproductive-Age Women: An Epidemiological Study in Chinese Communities

<div class="floats-full-page floats-full-page-other"><h2>Table 5</h2><div class="floats-full-page-caption"><div>The endocrine and metabolic assessment of PCOS group related to acne and non-PCOS group.</div></div><div class="floats-full-page-content"><table class="fixed-width table-group" id="tab5"><tr><td><table class="table"><colgroup><col style="width:7.03em" /><col style="width:2.43em" /><col style="width:4.97em" /><col style="width:4.97em" /><col style="width:4.97em" /><col style="width:6.54em" /><col style="width:6.83em" /><col style="width:5.24em" /><col style="width:6.80em" /></colgroup><tr><td class="thead-hr" colspan="9"><hr /></td></tr><tr class="thead"><td class="align_left" rowspan="2">Group</td><td class="align_center" rowspan="2">N</td><td class="align_center"><span style="width: 15.1954ptpx;"><svg height="10.1524pt" id="M13" style="vertical-align:-0.04990005pt" version="1.1" viewbox="-0.0498162 -10.1025 15.1954 10.1524" width="15.1954pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M673 0V28C608 34 594 43 563 129C499 303 432 494 370 665L339 656L132 132C98 43 84 37 20 28V0H238V28C162 35 154 45 175 108C188 150 203 192 219 237H432C454 176 474 122 487 83S491 36 428 28V0H673ZM418 280H234C265 362 296 450 328 535H330L418 280Z"></path></g><g transform="matrix(.0091,0,0,-0.0091,8.983,-5.741)"><path d="M486 158C486 177 478 202 466 220C413 228 386 236 336 262C386 288 413 297 466 304C478 323 486 347 485 366C470 376 444 381 422 380C389 338 368 319 321 288C323 345 329 372 349 422C339 442 322 461 305 470C289 461 271 442 262 422C281 372 287 345 290 288C243 319 222 338 189 380C167 381 142 376 125 366C125 347 133 322 145 304C198 296 225 288 275 262C225 236 198 227 145 220C133 201 125 177 126 158C141 148 167 143 189 144C222 186 243 205 290 236C288 179 282 152 262 102C272 82 289 63 306 54C322 63 340 82 350 102C330 152 324 179 321 236C368 205 390 186 422 144C444 143 470 148 486 158Z"></path></g></svg></span></td><td class="align_center">T</td><td class="align_center">SHBG</td><td class="align_center" rowspan="2">INS (mIU/L)</td><td class="align_center" rowspan="2">TSH (mIU/L)</td><td class="align_center">CHO</td><td class="align_center" rowspan="2">TG (mmol/L)</td></tr><tr class="thead"><td class="align_center">(nmol/L)</td><td class="align_center">(nmol/L)</td><td class="align_center">(nmol/L)</td><td class="align_center">(mmol/L)</td></tr><tr><td class="thead-hr" colspan="9"><hr /></td></tr><tr><td class="align_left" rowspan="2">PCOS group</td><td class="align_center" rowspan="2">59</td><td class="align_center">10.98±</td><td class="align_center">1.74±</td><td class="align_center">65.7±</td><td class="align_center">4.61±</td><td class="align_center">2.48±</td><td class="align_center">4.69±</td><td class="align_center">1.27±</td></tr><tr><td class="align_center">3.12</td><td class="align_center">0.78</td><td class="align_center">30.9</td><td class="align_center">1.91</td><td class="align_center">1.33</td><td class="align_center">2.01</td><td class="align_center">0.62</td></tr><tr><td class="align_left" rowspan="2">Control group</td><td class="align_center" rowspan="2">118</td><td class="align_center">8.85±</td><td class="align_center">1.41±</td><td class="align_center">67.35±</td><td class="align_center">3.95±</td><td class="align_center">2.93±</td><td class="align_center">4.36±</td><td class="align_center">1.06±</td></tr><tr><td class="align_center">3.09</td><td class="align_center">0.67</td><td class="align_center">29.8</td><td class="align_center">2.02</td><td class="align_center">1.42</td><td class="align_center">2.37</td><td class="align_center">0.49</td></tr><tr class="table-tr"><td colspan="9"><hr class="tbody-hr" /></td></tr></table></td></tr><tr class="table-fn"><td><div>Data are shown as the mean ± SD and were analyzed by t test. <svg height="10.1524pt" id="M14" style="vertical-align:-0.04990005pt" version="1.1" viewbox="-0.0498162 -10.1025 8.3578 10.1524" width="8.3578pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0091,0,0,-0.0091,2.179,-5.741)"><path d="M486 158C486 177 478 202 466 220C413 228 386 236 336 262C386 288 413 297 466 304C478 323 486 347 485 366C470 376 444 381 422 380C389 338 368 319 321 288C323 345 329 372 349 422C339 442 322 461 305 470C289 461 271 442 262 422C281 372 287 345 290 288C243 319 222 338 189 380C167 381 142 376 125 366C125 347 133 322 145 304C198 296 225 288 275 262C225 236 198 227 145 220C133 201 125 177 126 158C141 148 167 143 189 144C222 186 243 205 290 236C288 179 282 152 262 102C272 82 289 63 306 54C322 63 340 82 350 102C330 152 324 179 321 236C368 205 390 186 422 144C444 143 470 148 486 158Z"></path></g></svg>P&lt;0.05.<br /></div></td></tr></table></div></div>

Table 5 | How to Evaluate Acne in Reproductive-Age Women: An Epidemiological Study in Chinese Communities

title

Table 5: How to Evaluate Acne in Reproductive-Age Women: An Epidemiological Study in Chinese Communities

description

Table 5

About this journal

<p><em>BioMed Research International</em> publishes original research articles, review articles, and clinical studies covering a wide range of subjects within the biomedical sciences. The journal will accept both basic and translational research.</p>


Journal profile

Meet the editorial board

<p><em>BioMed Research International</em> maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.</p>


Editor spotlight

Submit to Special Issue

We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.